Analysis of Platelet Factor 3 in Platelet Concentrates Stored for Transfusion

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Vox Sanguinis

• Publication date

  1986-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1423-0410.1986.tb01972.xPMID 3798864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation.

  1985cited by this paper
• Comparison of the abilities of synthetic and platelet-derived membranes to enhance thrombin formation.

  1985cited by this paper
• Platelet metabolism during storage of platelet concentrates at 22 degrees C.

  1984cited by this paper
• Measurements of Platelet Function

  1984cited by this paper
• Stability of plasma fibrinogen during storage of platelet concentrates at 22° C

  1983cited by this paper
• Platelet storage at 22 degrees C for transfusion: interrelationship of platelet density and size, medium pH, and viability after in vivo infusion.

  1983cited by this paper
• Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.

  1982cited by this paper
• Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.

  1982cited by this paper
• Occurrence of the Release Reaction during Preparation and Storage of Platelet Concentrates

  1981cited by this paper
• Differentiation of factor V-like coagulant activity from catalytic phospholipid-like surface activity in membrane fractions derived from human platelets.

  1981cited by this paper
• Loss of 111Indium as indicator of platelet injury.

  1981cited by this paper
• Ultrastructural Lesions of Stored Platelets 1

  1981cited by this paper
• THE PLATELET MEMBRANE AS A CATALYTIC SURFACE IN THROMBIN GENERATION: AVAILABILITY OF PLATELET FACTOR 1 AND PLATELET FACTOR 3 *

  1981cited by this paper
• Buoyant density of platelets stored at room temperature as platelet concentrates.

  1981cited by this paper
• The Effect Of Prostacyclin (PGI2) On The Procoagulant Activity Of Human Platelets

  1981cited by this paper
• Coulter Counter and light transmission studies of platelets exposed to low temperature, ADP, EDTA, and storage at 22 degrees.

  1980cited by this paper
• A highly sensitive assay of platelet factor 3 using a chromogenic substrate.

  1979cited by this paper
• Platelet factor 3 : the link between platelets and plasma coagulation

  1979cited by this paper
• Platelet Coagulant Activities

  1978cited by this paper
• Platelet function.

  1977cited by this paper
• Conditions influencing platelet lysis.

  1975cited by this paper
• Platelet factor-3 availability and the platelet release reaction.

  1974cited by this paper
• Prothrombin activation.

  1974cited by this paper
• Kinetics of the thrombin-induced release of calcium (II) by platelets.

  1973cited by this paper
• In Vitro Analysis of Platelet Function During Storage of Platelets from Plasmapheresed Donors

  1973cited by this paper
• Platelet factor 3--properties and clinical significance.

  1972cited by this paper
• Platelet factor 3--methods of study.

  1972cited by this paper
• The role of lipids in blood coagulation.

  1966cited by this paper
• THE THROMBOPLASTIC COMPONENT OF INTACT BLOOD PLATELETS IS PRESENT IN MASKED FORM

  1958cited by this paper
• Estimation of serum phospholipide and total phosphorus using chloric acid.

  1958cited by this paper
• Isolation and properties of the third clotting factor in blood-platelets.

  1952cited by this paper
• Significance of clotting factors in blood-platelets, in normal and pathological conditions.

  1951cited by this paper

• Platelet Factor 3 Based-clotting Time Assay as a Quality Marker for Long-term Storage of Platelet Concentrates

  2016cites this paper
• The Regulatory Activities of recombinant Properdin and TSP1 on Platelet and Complement activation

  2016cites this paper
• The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression

  2016cites this paper
• Infusible platelet membrane as a platelet substitute for transfusion: an overview.

  2013cites this paper
• The clinical utility of thrombin generation

  2011cites this paper
• Intraoperatively salvaged red blood cells contain nearly no functionally active platelets, but exhibit formation of microparticles: results of a pilot study in orthopedic patients

  2010cites this paper
• Platelet senescence and phosphatidylserine exposure

  2010cites this paper
• A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation

  2007cites this paper
• CHAPTER 70 – Platelet Substitutes and Novel Methods of Platelet Preservation

  2007cites this paper
• The how and why of exocytic vesicles

  2006cites this paper
• Effects of storage‐induced platelet microparticles on the initiation and propagation phase of blood coagulation

  2006cites this paper
• Formation and fate of platelet microparticles.

  2006cites this paper
• Current methods of assessing platelet function: relevance to transfusion medicine

  2005cites this paper
• Potential involvement of Platelet-Derived microparticles during percutaneous transluminal coronary angioplasty

  2004cites this paper
• Flow cytometry of platelets for clinical analysis.

  2002cites this paper
• Novel treatment modalities: new platelet preparations and subsititutes

  2001cites this paper
• Platelet substitutes and novel platelet products

  2000cites this paper
• Generation of annexin V‐positive platelets and shedding of microparticles with stimulus‐dependent procoagulant activity during storage of platelets at 4°C

  2000cites this paper
• Microvesicles in platelet concentrates for transfusion.

  2000cites this paper
• Platelet microparticles: a wide-angle perspective.

  1999influential citation
• The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method

  1999cites this paper
• In comparison to progenitor platelets, microparticles are deficient in GpIb, GpIb-derived carbohydrates, glycerophospholipids, glycosphingolipids, and ceramides.

  1998cites this paper
• Novel platelet products and substitutes.

  1998cites this paper
• Platelet activation and its detection during the preparation of platelets for transfusion.

  1998cites this paper
• Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses.

  1995cites this paper
• Platelet microparticles bind, activate and aggregate neutrophils in vitro.

  1995cites this paper
• Masking of heparin activity in the activated coagulation time (ACT) by platelet procoagulant activity.

  1994cites this paper
• The role of platelet microparticles in hemostasis.

  1994cites this paper
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

  1994cites this paper
• Quantitative determination of circulating platelet microparticles by flow cytometry.

  1994cites this paper
• Effect of cold storage on platelet glycoprotein Ib and vesiculation

  1994cites this paper
• Proteolytic activity during storage of platelets in plasma

  1992cites this paper
• The use of inhibitors of platelet activation or protease activity in platelet concentrates stored for transfusion.

  1992cites this paper
• Stability of bovine platelets stored at ambient temperature

  1992cites this paper
• The role of membrane lipid in the platelet storage lesion.

  1992cites this paper
• Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

  1992cites this paper
• Vesiculation of platelets during in vitro aging.

  1991cites this paper
• The Effect of Lysed Platelets on Neutralization of Heparin In Vitro with Protamine as Measured by the Activated Coagulation Time (ACT)

  1991cites this paper
• Extended Storage of Platelets in an Artificial Medium with the Platelet Activation Inhibitors Prostaglandin E1 and Theophylline 1

  1991cites this paper
• Platelet activation may explain the storage lesion in platelet concentrates.

  1990cites this paper
• Plasma levels of ionized and total calcium during storage of citrated platelet concentrate

  1989cites this paper
• Plasmin activity and complement activation during storage of citrated platelet concentrates.

  1989cites this paper
• Effect of Centrifugation on the Storage Properties of Platelets

  1988cites this paper
• Changes in the activation state of stored platelets

  1988cites this paper
• Storage of human red blood cells and platelets. Some aspects concerning the factors leading to storage lesion characterized as morphological changes and vesiculation. Minireview based on a doctoral thesis.

  1988cites this paper
• Platelet storage lesion: formation of platelet fragments with platelet factor 3 activity.

  1987cites this paper
• Generation and Degradation of Fibrinopeptide A in Stored Platelet Concentrate

  1986cites this paper